20. |
PRINCIPAL SUBSIDIARIES AND JOINT VENTURES |
| |
|
|
|
Currency |
Issued capital |
Effective Group holding |
Investment |
Amounts (due to)/due by subsidiaries/joint ventures |
| |
Country of incorporation |
Company |
|
|
’000 |
2009
% |
2008
% |
2009
R’million |
2008
R’million |
2009
R’million |
2008
R’million |
| |
Subsidiaries |
|
|
|
|
|
|
|
|
|
|
| |
Direct |
|
|
|
|
|
|
|
|
|
|
| |
Mauritius |
Aspen Global Incorporated |
|
USD |
444 378 |
100 |
100 |
3 373,4 |
1 509,8 |
26,3 |
0,8 |
| |
South Africa |
Aspen OSD (Pty) Ltd |
|
ZAR |
— # |
100 |
100 |
9,8 |
9,8 |
(27,1) |
(27,1) |
| |
United Kingdom |
Aspen Pharmacare International Ltd* |
|
GBP |
— # |
100 |
100 |
— |
225,5 |
— |
— |
| |
South Africa |
Aspen Pharmacare International (Pty) Ltd |
|
ZAR |
— # |
100 |
100 |
25,4 |
25,4 |
(29,1) |
(29,1) |
| |
United States |
Aspen USA Incorporated |
|
USD |
1 270 |
100 |
100 |
8,1 |
8,1 |
— |
— |
| |
Australia |
Brimpharm Australia Pty Ltd |
|
AUD |
— # |
50 |
50 |
— |
— |
1,8 |
1,5 |
| |
South Africa |
Brimpharm SA (Pty) Ltd |
|
ZAR |
4 |
50 |
50 |
40,5 |
40,5 |
— |
— |
| |
United Kingdom |
Brimpharm UK Ltd |
|
GBP |
— # |
50 |
50 |
— |
— |
— |
— |
| |
South Africa |
Fine Chemicals Corporation (Pty) Ltd** |
|
ZAR |
— |
100 |
50 |
328,4 |
— |
— |
— |
| |
South Africa |
Pharmacare Ltd |
|
ZAR |
1 285 |
100 |
100 |
589,2 |
567,9 |
(232,3) |
(240,8) |
| |
Jersey, CI |
SAD Overseas Ltd |
|
GBP |
19 |
100 |
100 |
— |
— |
— |
— |
| |
Kenya |
Shelys Africa Ltd |
|
KES |
196 198 |
60 |
60 |
231,5 |
231,5 |
74,0 |
71,5 |
| |
South Africa |
Twincor Investments (Pty) Ltd |
|
ZAR |
260 |
100 |
100 |
5,2 |
5,2 |
(1,4) |
(1,4) |
| |
Indirect |
|
|
|
|
|
|
|
|
|
|
| |
South Africa |
Abe Krok Investments (Pty) Ltd |
|
ZAR |
— # |
100 |
100 |
— |
— |
— |
— |
| |
South Africa |
Abkro Investments (Pty) Ltd |
|
ZAR |
— # |
100 |
100 |
— |
— |
— |
— |
| |
United Arab Emirates |
Aspen Health Care FZ LLC |
|
USD |
82 |
100 |
— |
— |
— |
— |
— |
| |
South Africa |
Aspen International Distribution (Pty) Ltd |
|
ZAR |
1 |
100 |
100 |
— |
— |
— |
— |
| |
South Africa |
Aspen Nutritionals (Pty) Ltd |
|
ZAR |
1 |
100 |
100 |
— |
— |
— |
— |
| |
South Africa |
Aspen Pharmacare Africa (Pty) Ltd |
|
ZAR |
1 |
100 |
100 |
— |
— |
— |
— |
| |
Australia |
Aspen Pharmacare Australia Pty Ltd |
|
AUD |
17 373 |
100 |
100 |
— |
— |
— |
— |
| |
South Africa |
Aspen Pharmacare East London (Pty) Ltd |
|
ZAR |
1 |
100 |
100 |
— |
— |
— |
— |
| |
United Kingdom |
Aspen Pharmacare Resources Ltd |
|
GBP |
— # |
100 |
100 |
— |
— |
— |
— |
| |
South Africa |
Aspen Pharmacare South Africa (Pty) Ltd |
|
ZAR |
— # |
100 |
100 |
— |
— |
0,8 |
0,8 |
| |
South Africa |
Aspen Port Elizabeth (Pty) Ltd (previously Aspen SVP (Pty) Ltd) |
|
ZAR |
400 |
100 |
100 |
— |
— |
— |
— |
| |
Kenya |
Beta Healthcare International Ltd |
|
KES |
30 000 |
60 |
60 |
— |
— |
— |
— |
| |
Kenya |
Beta Healthcare (Kenya) Ltd |
|
KES |
20 000 |
60 |
60 |
— |
— |
— |
— |
| |
Uganda |
Beta Healthcare (Uganda) Ltd |
|
UGX |
40 000 |
60 |
60 |
— |
— |
— |
— |
| |
South Africa |
Brovar (Pty) Ltd |
|
ZAR |
— # |
100 |
100 |
— |
— |
— |
— |
| |
Venezuela |
Casa de Reresentaciones Sumifarma, C.A.^ |
|
VEF |
2 729 |
80 |
40 |
— |
— |
— |
— |
| |
Brazil |
Cellofarm Ltda^ |
|
BRL |
214 537 |
100 |
50 |
— |
— |
— |
— |
| |
South Africa |
Krok Brothers Holdings (Pty) Ltd |
|
ZAR |
— # |
100 |
100 |
2,2 |
2,2 |
(47,7) |
(47,7) |
| |
South Africa |
Malcomess Leasing Company (Pty) Ltd |
|
ZAR |
— # |
100 |
100 |
— |
— |
— |
— |
| |
Cyprus |
PharmaLatina Holdings Ltd^ |
|
USD |
12 927 |
100 |
50 |
— |
— |
— |
— |
| |
Tanzania |
Shelys Pharmaceuticals Ltd |
|
TZS |
6 723 843 |
60 |
60 |
— |
— |
— |
— |
| |
Mauritius |
Shelys Pharmaceuticals International Ltd |
|
USD |
— # |
60 |
60 |
— |
— |
— |
— |
| |
South Africa |
Skay Investments (Pty) Ltd |
|
ZAR |
— # |
100 |
100 |
— |
— |
— |
— |
| |
Mexico |
Solara, S.A. de C.V.^ |
|
MXN |
93 124 |
100 |
50 |
— |
— |
— |
— |
| |
South Africa |
Sol Krok Investments (Pty) Ltd |
|
ZAR |
— # |
100 |
100 |
— |
— |
— |
— |
| |
South Africa |
Solo Ethicals (Pty) Ltd |
|
ZAR |
1 |
100 |
100 |
— |
— |
— |
— |
| |
Cyprus |
Strides Latina S.A.^ |
|
USD |
2 926 |
100 |
50 |
— |
— |
— |
— |
| |
Mexico |
Strides Mexicana, S.A. de C.V.^ |
|
MXN |
5 415 |
100 |
50 |
— |
— |
— |
— |
| |
Total investments in subsidiaries |
|
|
|
|
|
4 613,7 |
2 625,9 |
(234,7) |
(271,5) |
| |
Joint ventures |
|
|
|
|
|
|
|
|
|
|
| |
Direct |
|
|
|
|
|
|
|
|
|
|
| |
India |
Astrix Laboratories Ltd |
|
INR |
45 250 |
— |
50 |
— |
232,9 |
— |
— |
| |
South Africa |
Fine Chemicals Corporation (Pty) Ltd** |
|
ZAR |
— # |
100 |
50 |
— |
137,8 |
— |
— |
| |
Indirect |
|
|
|
|
|
|
|
|
|
|
| |
India |
Onco Therapies Ltd |
|
INR |
20 256 |
49 |
49 |
— |
— |
— |
— |
| |
Cyprus |
Onco Laboratories Ltd |
|
USD |
6 |
50 |
50 |
— |
— |
— |
— |
| |
Total investments in joint ventures |
|
|
|
|
|
— |
370,7 |
— |
— |
| |
Total investments in subsidiaries and joint ventures |
|
|
|
|
|
4 613,7 |
2 996,6 |
(234,7) |
(271,5) |
| |
#Less than 1 000.
*During the year a share capital reduction occurred which reduced the investment to zero.
**On 31 May 2009, the Group acquired the remaining shareholding in FCC. The company is classified as a subsidiary in 2009, compared to being a joint venture in 2008.
^These investments were shown as indirect joint ventures in the 2008 financial year. |
|
| |
The Group maintains a register of all subsidiaries and incorporated joint ventures, available for inspection at the registered office of Aspen Pharmacare Holdings Ltd. |
|
